位置:首页 > 蛋白库 > SP2SA_BACSU
SP2SA_BACSU
ID   SP2SA_BACSU             Reviewed;         248 AA.
AC   O34853;
DT   03-APR-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   03-AUG-2022, entry version 112.
DE   RecName: Full=Stage II sporulation protein SA;
DE   AltName: Full=Killer protein SpoIISA;
DE   AltName: Full=Toxin SpoIISA;
GN   Name=spoIISA; Synonyms=ykaC; OrderedLocusNames=BSU12830;
OS   Bacillus subtilis (strain 168).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=224308;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=168;
RA   Devine K.M.;
RT   "Sequence of the Bacillus subtilis genome between xlyA and ykoR.";
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=168;
RX   PubMed=9384377; DOI=10.1038/36786;
RA   Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V.,
RA   Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R.,
RA   Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S.,
RA   Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K.,
RA   Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F.,
RA   Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D.,
RA   Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M.,
RA   Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P.,
RA   Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K.,
RA   Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S.,
RA   Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y.,
RA   Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G.,
RA   Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J.,
RA   Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C.,
RA   Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S.,
RA   Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B.,
RA   Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S.,
RA   Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M.,
RA   Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y.,
RA   Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J.,
RA   Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A.,
RA   Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M.,
RA   Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S.,
RA   Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E.,
RA   Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K.,
RA   Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E.,
RA   Yoshikawa H., Danchin A.;
RT   "The complete genome sequence of the Gram-positive bacterium Bacillus
RT   subtilis.";
RL   Nature 390:249-256(1997).
RN   [3]
RP   FUNCTION AS A TOXIN, SUBUNIT, MUTAGENESIS OF ARG-38 AND LEU-103, INDUCTION,
RP   AND DISRUPTION PHENOTYPE.
RC   STRAIN=168 / JH642;
RX   PubMed=11371520; DOI=10.1128/jb.183.12.3574-3581.2001;
RA   Adler E., Barak I., Stragier P.;
RT   "Bacillus subtilis locus encoding a killer protein and its antidote.";
RL   J. Bacteriol. 183:3574-3581(2001).
RN   [4]
RP   EXPRESSION IN E.COLI.
RC   STRAIN=168 / JH642;
RX   PubMed=18096016; DOI=10.1111/j.1574-6968.2007.00984.x;
RA   Florek P., Muchova K., Pavelcikova P., Barak I.;
RT   "Expression of functional Bacillus SpoIISAB toxin-antitoxin modules in
RT   Escherichia coli.";
RL   FEMS Microbiol. Lett. 278:177-184(2008).
RN   [5]
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RC   STRAIN=168 / PY79;
RX   PubMed=20863891; DOI=10.1016/j.resmic.2010.09.005;
RA   Resetarova S., Florek P., Muchova K., Wilkinson A.J., Barak I.;
RT   "Expression and localization of SpoIISA toxin during the life cycle of
RT   Bacillus subtilis.";
RL   Res. Microbiol. 161:750-756(2010).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 92-248, AND INTERACTION WITH
RP   SPOIISB.
RC   STRAIN=168 / PY79;
RX   PubMed=21147767; DOI=10.1074/jbc.m110.172429;
RA   Florek P., Levdikov V.M., Blagova E., Lebedev A.A., Skrabana R.,
RA   Resetarova S., Pavelcikova P., Barak I., Wilkinson A.J.;
RT   "The structure and interactions of SpoIISA and SpoIISB, a toxin-antitoxin
RT   system in Bacillus subtilis.";
RL   J. Biol. Chem. 286:6808-6819(2011).
CC   -!- FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Its
CC       toxic activity is neutralized by cognate antitoxin SpoIISB. Expression
CC       in the absence of SpoIISB permits sporulation to stage II, when
CC       plasmolysis zones and holes in the peptidoglycan layer are observed,
CC       resulting in cell death. Lethal when synthesized during vegetative
CC       growth in the absence of SpoIISB. In E.coli both the membrane bound and
CC       soluble domain are required in cis for toxin activity.
CC       {ECO:0000269|PubMed:11371520}.
CC   -!- SUBUNIT: Probably forms an oligomer; X-ray data suggests the inactive
CC       complex forms a heterotetramer of SpoIISA(2)-SpoIISB(2), which
CC       inactivates the toxic activity of SpoIISA.
CC       {ECO:0000269|PubMed:11371520}.
CC   -!- INTERACTION:
CC       O34853; O34800: spoIISB; NbExp=3; IntAct=EBI-4406150, EBI-4406141;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:20863891};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:20863891}.
CC   -!- INDUCTION: Expressed at low levels during exponential growth, it
CC       increases dramatically at the onset of sporulation (at protein level).
CC       A member of the spoIISA-spoIISB operon. {ECO:0000269|PubMed:11371520,
CC       ECO:0000269|PubMed:20863891}.
CC   -!- DISRUPTION PHENOTYPE: No change in sporulation efficiency.
CC       {ECO:0000269|PubMed:11371520}.
CC   -!- SIMILARITY: Belongs to the SpoIISA toxin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ002571; CAA05563.1; -; Genomic_DNA.
DR   EMBL; AL009126; CAB13140.1; -; Genomic_DNA.
DR   PIR; D69713; D69713.
DR   RefSeq; NP_389166.1; NC_000964.3.
DR   RefSeq; WP_003244695.1; NZ_JNCM01000035.1.
DR   PDB; 3O6Q; X-ray; 2.50 A; A/C=92-248.
DR   PDBsum; 3O6Q; -.
DR   AlphaFoldDB; O34853; -.
DR   SMR; O34853; -.
DR   IntAct; O34853; 1.
DR   STRING; 224308.BSU12830; -.
DR   TCDB; 9.A.10.1.1; the oligomeric probable pore-forming spoiia toxin (spoiia) family.
DR   PaxDb; O34853; -.
DR   PRIDE; O34853; -.
DR   EnsemblBacteria; CAB13140; CAB13140; BSU_12830.
DR   GeneID; 938174; -.
DR   KEGG; bsu:BSU12830; -.
DR   PATRIC; fig|224308.179.peg.1392; -.
DR   eggNOG; ENOG5033VU0; Bacteria.
DR   OMA; AIRKTWY; -.
DR   BioCyc; BSUB:BSU12830-MON; -.
DR   Proteomes; UP000001570; Chromosome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030435; P:sporulation resulting in formation of a cellular spore; IEA:UniProtKB-KW.
DR   InterPro; IPR025940; SpoIISA_toxin.
DR   Pfam; PF14171; SpoIISA_toxin; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Membrane; Reference proteome; Sporulation;
KW   Toxin-antitoxin system; Transmembrane; Transmembrane helix.
FT   CHAIN           1..248
FT                   /note="Stage II sporulation protein SA"
FT                   /id="PRO_0000072062"
FT   TOPO_DOM        1..3
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4..21
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        22..41
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        42..64
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        65..67
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        68..87
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        88..248
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         38
FT                   /note="R->Q: Loss of toxicity."
FT                   /evidence="ECO:0000269|PubMed:11371520"
FT   MUTAGEN         103
FT                   /note="L->F: In mut9; sporulation efficiency decreases by
FT                   about 4 orders of magnitude."
FT                   /evidence="ECO:0000269|PubMed:11371520"
FT   HELIX           98..126
FT                   /evidence="ECO:0007829|PDB:3O6Q"
FT   STRAND          129..135
FT                   /evidence="ECO:0007829|PDB:3O6Q"
FT   HELIX           136..152
FT                   /evidence="ECO:0007829|PDB:3O6Q"
FT   TURN            153..155
FT                   /evidence="ECO:0007829|PDB:3O6Q"
FT   STRAND          156..162
FT                   /evidence="ECO:0007829|PDB:3O6Q"
FT   HELIX           166..173
FT                   /evidence="ECO:0007829|PDB:3O6Q"
FT   HELIX           179..187
FT                   /evidence="ECO:0007829|PDB:3O6Q"
FT   STRAND          197..206
FT                   /evidence="ECO:0007829|PDB:3O6Q"
FT   STRAND          209..216
FT                   /evidence="ECO:0007829|PDB:3O6Q"
FT   HELIX           223..239
FT                   /evidence="ECO:0007829|PDB:3O6Q"
SQ   SEQUENCE   248 AA;  29061 MW;  16E9CA02AEAF2F6D CRC64;
     MVLFFQIMVW CIVAGLGLYV YATWRFEAKV KEKMSAIRKT WYLLFVLGAM VYWTYEPTSL
     FTHWERYLIV AVSFALIDAF IFLSAYVKKL AGSELETDTR EILEENNEML HMYLNRLKTY
     QYLLKNEPIH VYYGSIDAYA EGIDKLLKTY ADKMNLTASL CHYSTQADKD RLTEHMDDPA
     DVQTRLDRKD VYYDQYGKVV LIPFTIETQN YVIKLTSDSI VTEFDYLLFT SLTSIYDLVL
     PIEEEGEG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024